Patent Assignment
Reel/Frame 064180/0456
Release of Certain Intellectual Property Collateral Owned by Wellstat Therapeutics Corporation Recorded at Reel 031227/Frame 0227
Recorded: 2023-06-30
Pages: 7
Assignor
PDL BIOPHARMA, INC.
Executed: 2023-06-30
Assignee
WELLSTAT THERAPEUTICS CORPORATION
14200 SHADY GROVE ROAD, SUITE 600, ROCKVILLE, MARYLAND, 20850
Covered Properties
(2)
Treatment of Chemotherapeutic Agent and Antiviral Agent Toxicity with Acylated Pyrimidine Nucleosides
Patent:
7,776,838 →
Application:
08/460,186 →
Acylated Uridine and Cytidine and Uses Thereof
Patent:
6,258,795 →
Application:
08/466,145 →
Related Assignments
(8)
Other recorded transfers of the patents in this record — the chain of ownership.
Security Agreement
Aug 16, 2013
From: WELLSTAT THERAPEUTICS CORPORATION
To: WHITE OAK GLOBAL ADVISORS, LLC, AS ADMINISTRATIVE AGENT
Reel/Frame 031029/0875 →
Security Agreement
Sep 18, 2013
From: WELLSTAT THERAPEUTICS CORPORATION
To: PDL BIOPHARMA, INC.
Reel/Frame 031227/0227 →
Change of Name
Sep 5, 2014
From: PRO-NEURON, INC.
To: WELLSTAT THERAPEUTICS CORPORATION
Reel/Frame 033692/0660 →
Merger
Sep 5, 2014
From: WELLSTAT THERAPEUTICS CORPORATION
To: WELLSTAT THERAPEUTICS CORPORATION
Reel/Frame 033674/0573 →
Assignment of Assignor's Interest
Sep 5, 2014
From: VON BORSTEL, REID W.; BAMAT, MICHAEL K.
To: WELLSTAT THERAPEUTICS CORPORATION
Reel/Frame 033674/0729 →
Release of Security Interest
Jan 21, 2021
From: WHITE OAK GLOBAL ADVISORS, LLC, AS ADMINISTRATIVE AGENT
To: WELLSTAT THERAPEUTICS CORPORATION
Reel/Frame 055056/0891 →
Assignment of Assignor's Interest
Oct 30, 2024
From: WELLSTAT THERAPEUTICS CORPORATION
To: BTG INTERNATIONAL INC.
Reel/Frame 069079/0028 →
Assignment of Assignor's Interest
Nov 14, 2024
From: WELLSTAT THERAPEUTICS CORPORATION
To: BTG INTERNATIONAL INC.
Reel/Frame 069259/0699 →